Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06716411

Confirming the Effects of Acupuncture Treatments to Relieve Symptoms of Gulf War Illness

Led by University of Utah · Updated on 2026-04-03

200

Participants Needed

10

Research Sites

138 weeks

Total Duration

On this page

Sponsors

U

University of Utah

Lead Sponsor

U

United States Department of Defense

Collaborating Sponsor

AI-Summary

What this Trial Is About

This unblinded Phase II clinical trial will test the effects of individualized acupuncture treatments offered in extant acupuncture practices in the community; practitioners will have had at least 5 years of experience plus additional training provided by the study. Veterans with diagnosed symptoms of Gulf War Illness will be randomized to either six months of biweekly acupuncture treatments (group 1, n=100) or 2 months of waitlist followed by weekly acupuncture treatments (group 2, n=100). Measurements were taken at baseline, 2, 4 and 6 months. The primary outcome is the SF-36 physical component scale score (SF-36P).

CONDITIONS

Official Title

Confirming the Effects of Acupuncture Treatments to Relieve Symptoms of Gulf War Illness

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Deployed to the Gulf Theater of operations between August 1990 and the present date
  • Have at least 2 of the following symptom clusters lasting more than 6 months: fatigability (fatigue 24 hours or more after exertion), mood and cognition issues (depression, irritability, concentration difficulties, anxiety, sleep problems), musculoskeletal pain (joint or muscle pain)
  • Each symptom cluster must be rated mild-moderate or severe, with at least one symptom in each cluster being severe
Not Eligible

You will not qualify if you...

  • Currently enrolled in another clinical trial
  • Have another disease likely explaining the symptoms, as determined by Medical Monitor
  • Severe psychiatric illness in the last 2 years, including psychiatric hospitalization, suicidal attempt, alcohol or substance abuse, or use of antipsychotic medication
  • Unable to complete the study protocol based on Medical Monitor evaluation

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 10 locations

1

University of California, Berkeley

Berkeley, California, United States, 94720

Not Yet Recruiting

2

Various

Los Angeles, California, United States, 90015

Actively Recruiting

3

Various

Colorado Springs, Colorado, United States, 80911

Not Yet Recruiting

4

Various

Denver, Colorado, United States, 80203

Not Yet Recruiting

5

Various

Tampa, Florida, United States, 33762

Actively Recruiting

6

Beth Israel Deaconess Medical Center

Boston, Massachusetts, United States, 02215

Not Yet Recruiting

7

Various

Dallas, Texas, United States, 75231

Actively Recruiting

8

University of Utah

Salt Lake City, Utah, United States, 84111

Not Yet Recruiting

9

Various

Fairfax, Virginia, United States, 23235

Not Yet Recruiting

10

Various

Seattle, Washington, United States, 98116

Not Yet Recruiting

Loading map...

Research Team

L

Lisa Conboy

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here